Rising Childhood Cancer Rates in Sverdlovsk Oblast: Early Detection and Prevention
Childhood cancer rates in Sverdlovsk Oblast, Russia, are 15.6 per 100,000 children, increasing due to better detection, with most cases diagnosed in early stages. Common cancers include blood/lymph diseases and CNS tumors, linked to genetics, parental lifestyle, and environmental factors. Early dete...
Rising Childhood Cancer Rates in Sverdlovsk Oblast: Early Detection and Prevention
Childhood cancer rates in Sverdlovsk Oblast, Russia, are 15.6 per 100,000 children, increasing due to better detection, with most cases diagnosed in early stages. Common cancers include blood/lymph diseases and CNS tumors, linked to genetics, parental lifestyle, and environmental factors. Early dete...
Progress
20% Bias Score
19-Year Remission Achieved in Neuroblastoma Patient Treated with CAR-T Cells
A 4-year-old girl treated for neuroblastoma in 2006 at Texas Children's Hospital with experimental CAR-T cell therapy remains cancer-free 19 years later, representing the longest remission ever reported for this treatment and offering new hope for solid tumor therapies.
19-Year Remission Achieved in Neuroblastoma Patient Treated with CAR-T Cells
A 4-year-old girl treated for neuroblastoma in 2006 at Texas Children's Hospital with experimental CAR-T cell therapy remains cancer-free 19 years later, representing the longest remission ever reported for this treatment and offering new hope for solid tumor therapies.
Progress
48% Bias Score
Heidelberg Center Develops Innovative Mini-Tumor Approach to Combat Childhood Cancer
Over 275,000 children globally were diagnosed with cancer in 2022, resulting in over 105,000 deaths; the Heidelberg KiTZ center uses mini-tumors to test 80 drugs, finding a suitable treatment in 80% of over 500 tested samples, highlighting a critical need for specialized pediatric cancer treatments.
Heidelberg Center Develops Innovative Mini-Tumor Approach to Combat Childhood Cancer
Over 275,000 children globally were diagnosed with cancer in 2022, resulting in over 105,000 deaths; the Heidelberg KiTZ center uses mini-tumors to test 80 drugs, finding a suitable treatment in 80% of over 500 tested samples, highlighting a critical need for specialized pediatric cancer treatments.
Progress
36% Bias Score
NIH Funding Cuts Threaten Children with Rare Cancers
Six-year-old Cailen Vela battles a rare, aggressive cancer that has relapsed, requiring extensive treatment and placing a strain on his family; proposed NIH funding cuts threaten access to advanced therapies for him and other children with similar conditions.
NIH Funding Cuts Threaten Children with Rare Cancers
Six-year-old Cailen Vela battles a rare, aggressive cancer that has relapsed, requiring extensive treatment and placing a strain on his family; proposed NIH funding cuts threaten access to advanced therapies for him and other children with similar conditions.
Progress
56% Bias Score
Improved Childhood Cancer Survival in the Netherlands
New data from the Dutch Cancer Registry shows that the five-year survival rate for children with cancer has risen from 74 percent (1990-1999) to 84 percent (2010-2018), thanks to improved diagnoses and targeted treatments; however, significant disparities remain across cancer types, with high-grade ...
Improved Childhood Cancer Survival in the Netherlands
New data from the Dutch Cancer Registry shows that the five-year survival rate for children with cancer has risen from 74 percent (1990-1999) to 84 percent (2010-2018), thanks to improved diagnoses and targeted treatments; however, significant disparities remain across cancer types, with high-grade ...
Progress
28% Bias Score
Childhood Obesity Linked to Increased Relapse and Death Risk in Pediatric Cancer
A Canadian study of over 11,000 pediatric cancer patients (ages 2-19) revealed that obese children had a 16% higher relapse risk and a 29% higher death risk within five years, emphasizing the urgent need to address childhood obesity due to its significant impact on cancer outcomes.
Childhood Obesity Linked to Increased Relapse and Death Risk in Pediatric Cancer
A Canadian study of over 11,000 pediatric cancer patients (ages 2-19) revealed that obese children had a 16% higher relapse risk and a 29% higher death risk within five years, emphasizing the urgent need to address childhood obesity due to its significant impact on cancer outcomes.
Progress
20% Bias Score